What are the consensus estimates for NUMINUS WELLNESS INC (NUMI.CA) next earnings?
The consensus EPS estimate for the next earnings of NUMINUS WELLNESS INC (NUMI.CA) is -0.01 CAD and the consensus revenue estimate is 4.69M CAD.
NUMINUS WELLNESS INC (NUMI.CA) Forecast, Price Target & Analyst Ratings
TSX:NUMI • CA67054W1032
Current stock price
0.05 CAD
+0.02 (+42.86%)
Last:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for NUMINUS WELLNESS INC (NUMI.CA).
Forecast Snapshot
Next Earnings Forecast
Earnings Estimate- Release Date
- N/A
- Period
- Q4 / 2024
- EPS Estimate
- -CA$0.01
- Revenue Estimate
- 4.693M
Price Target Details & History
Consensus Price Target and Range
Mean target
N/A
Upside
N/A
From current price of CA$0.05 to mean target of N/A, Based on 7 analyst forecasts
Low
N/A
Median
N/A
High
N/A
Price Target Revisions
1 Month
0.00%
3 Months
0.00%
Price Target Summary
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
82.86%
NUMI.CA was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about NUMI.CA.
In the previous month the buy percentage consensus was at a similar level.
NUMI.CA was analyzed by 7 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2021-09-15 | Eight Capital | Initiate | Buy |
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- N/A
- Period
- Q4 / 2024
- EPS Estimate
- -CA$0.01
- Revenue Estimate
- 4.693M
- Revenue Q2Q
- -23.44%
- EPS Q2Q
- 66.67%
- Number of Analysts
- 3
Next Earnings Revisions
Revenue (1 Month)
0.00%
Revenue (3 Months)
0.00%
EPS (1 Month)
0.00%
EPS (3 Months)
0.00%
Next Earnings Summary
The next earnings revenue estimate has been revised downward by 0% in the past 3 months.
Full Analyst Estimates 2024 - 2031
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 1.51M 71.59% | 6.49M 329.80% | 23.18M 257.16% | 20.326M -12.31% | 24.577M 20.91% | 34.805M 41.62% | 52.944M 52.12% | 68.769M 29.89% | 77.931M 13.32% | 86.884M 11.49% | 96.896M 11.52% | |
| EBITDA YoY % growth | -15.13M -126.84% | -26.94M -78.06% | -24.13M 10.43% | -12.021M 50.18% | 2.883M 123.98% | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -15.85M -117.72% | -28.45M -79.50% | -26.96M 5.24% | -16.454M 38.97% | -8.244M 49.90% | -2.582M 68.68% | 8.143M 415.42% | 16.457M 102.10% | 20.714M 25.87% | 24.784M 19.65% | 29.423M 18.72% | |
| Operating Margin | -1,049.67% | -438.37% | -116.31% | -80.95% | -33.54% | -7.42% | 15.38% | 23.93% | 26.58% | 28.53% | 30.37% | |
| EPS YoY % growth | N/A | N/A | N/A -20.00% | -0.05 58.33% | -0.01 80.00% | 0.00 100.00% | 0.12 | 0.20 72.73% | 0.24 21.05% | 0.28 13.04% | N/A |
All data in CAD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.01 66.67% | 0.00 | 0.00 | 0.00 100.00% | 0.00 100.00% | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Q2Q % growth | 4.693M -23.44% | 5.404M -9.12% | 5.897M -38.72% | 6.39M 46.94% | 6.886M 46.73% | 7.946M 47.04% | 8.354M 41.67% | 9.049M 41.61% | 9.456M 37.32% |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -2.888M 52.43% | -2.164M 48.03% | -2.018M 76.99% | -2.056M 48.02% | -2.005M 30.55% | -626.28K 71.07% | -619.14K 69.31% | -671.16K 67.36% | -664.02K 66.89% |
All data in CAD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
25.99%
EPS Next 5 Year
29.53%
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
11.96%
Revenue Next 5 Year
22.63%
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
NUMINUS WELLNESS INC / NUMI.CA Forecast FAQ
What is the number of analysts for NUMI stock?
The number of analysts covering NUMINUS WELLNESS INC (NUMI.CA) is 7.